303. AAV Capsid Evolution for Enhanced Antibody Delivery to Human Muscle for Use in Next-Generation HIV Vaccines
Molecular Therapy - United States
doi 10.1016/s1525-0016(16)33912-0
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2015
Authors
Publisher
Elsevier BV